
Glimisil-MV 2.3 Tablet SR
Marketer
Sansill Formulations
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimisil-MV 2.3 Tablet SR
Diabexe-Duo 2.3 SR tablets are classified as antidiabetic medications. This dual-action formulation is indicated for managing type 2 diabetes in adult patients. Its primary function is to regulate blood glucose. Diabexe-Duo 2.3 SR tablets should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with well-managed blood sugar, as abrupt cessation can lead to hyperglycemia, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are integral to effective diabetes control. The most prevalent adverse reaction is hypoglycemia (low blood sugar). Learn to identify symptoms—sweating, lightheadedness, headache, tremor—and implement appropriate countermeasures. Maintain regular mealtimes and carry a rapid-acting glucose source, like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment; it may be unsuitable. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Glimisil-MV 2.3 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimisil-MV 2.3 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimisil-MV 2.3 Tablet SR on an empty stomach.
Common Side effects of Glimisil-MV 2.3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimisil-MV 2.3 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimisil-MV 2.3 Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this medication on an empty stomach.
How Glimisil-MV 2.3 Tablet SR works:
Extended-release Glimisil-MV 2.3 tablets contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimisil-MV 2.3 Tablet SR and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimisil-MV 2.3 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimisil-MV 2.3mg tablet is likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyUNSAFE
Extended-release Glimisil-MV 2.3 mg tablets are contraindicated in individuals with renal impairment and should be omitted. Physician consultation is advised. Their use is similarly discouraged for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimisil-MV 2.3 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A low initial dose is typically prescribed for individuals with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glimisil-MV 2.3 Tablet SR :
Should you forget to take a Glimisil-MV 2.3 Tablet SR, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimisil-MV 2.3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
